NeuroPace, Inc. (NPCE)
USD 13.01
(-3.91%)
USD 13.01
(-3.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -27.17 Million USD | 33.39% |
| 2022 | -40.79 Million USD | -71.86% |
| 2021 | -23.73 Million USD | -81.88% |
| 2020 | -13.05 Million USD | 40.76% |
| 2019 | -22.03 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -6.23 Million USD | 17.43% |
| 2024 Q1 | -7.54 Million USD | -49.38% |
| 2023 Q2 | -7.85 Million USD | 5.59% |
| 2023 Q1 | -8.31 Million USD | 15.62% |
| 2023 FY | -27.17 Million USD | 33.39% |
| 2023 Q4 | -5.05 Million USD | 15.11% |
| 2023 Q3 | -5.95 Million USD | 24.24% |
| 2022 Q2 | -10.97 Million USD | -12.42% |
| 2022 Q1 | -9.76 Million USD | -8.29% |
| 2022 Q3 | -10.19 Million USD | 7.06% |
| 2022 FY | -40.79 Million USD | -71.86% |
| 2022 Q4 | -9.85 Million USD | 3.33% |
| 2021 Q2 | -4.6 Million USD | -18.87% |
| 2021 FY | -23.73 Million USD | -81.88% |
| 2021 Q4 | -9.01 Million USD | -44.4% |
| 2021 Q3 | -6.24 Million USD | -35.57% |
| 2021 Q1 | -3.87 Million USD | -29.96% |
| 2020 Q3 | -1.16 Million USD | 66.16% |
| 2020 Q2 | -3.44 Million USD | 36.86% |
| 2020 Q1 | -5.45 Million USD | 0.0% |
| 2020 FY | -13.05 Million USD | 40.76% |
| 2020 Q4 | -2.98 Million USD | -155.66% |
| 2019 FY | -22.03 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -89.221% |
| Cerus Corporation | -30.05 Million USD | 9.58% |
| OrthoPediatrics Corp. | -25.76 Million USD | -5.465% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -155.843% |
| Talis Biomedical Corporation | -66.81 Million USD | 59.329% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -57.111% |
| Inogen, Inc. | -109.38 Million USD | 75.158% |
| Spectral AI, Inc. | -12.98 Million USD | -109.288% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 56.583% |
| CVRx, Inc. | -43.1 Million USD | 36.956% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -670.238% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -118.651% |
| Orthofix Medical Inc. | -139.11 Million USD | 80.466% |
| Venus Concept Inc. | -28.3 Million USD | 4.009% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 49.704% |
| Bioventus Inc. | -81.72 Million USD | 66.749% |
| BrainsWay Ltd. | -4.92 Million USD | -451.532% |
| Envoy Medical, Inc. | -18.37 Million USD | -47.918% |
| electroCore, Inc. | -18.8 Million USD | -44.504% |
| IceCure Medical Ltd | -15.57 Million USD | -74.461% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 43.95% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -57.366% |
| MaxCyte, Inc. | -48.29 Million USD | 43.738% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -127.298% |
| Nexalin Technology, Inc. | -5.69 Million USD | -377.047% |
| PAVmed Inc | -68.79 Million USD | 60.5% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 51.958% |
| RxSight, Inc. | -50.08 Million USD | 45.744% |
| Sight Sciences, Inc. | -57.27 Million USD | 52.554% |
| SI-BONE, Inc. | -46.93 Million USD | 42.098% |
| TELA Bio, Inc. | -44.07 Million USD | 38.346% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 49.817% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 47.161% |
| LivaNova PLC | -68.49 Million USD | 60.329% |
| 908 Devices Inc. | -42.75 Million USD | 36.447% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 84.328% |
| Nemaura Medical Inc. | -9.59 Million USD | -183.203% |
| LENSAR, Inc. | -12.22 Million USD | -122.21% |
| Apyx Medical Corporation | -17.25 Million USD | -57.448% |
| Cutera, Inc. | -156.23 Million USD | 82.606% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -215.83% |
| BioSig Technologies, Inc. | -28.51 Million USD | 4.693% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 68.993% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -21.064% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 124.366% |
| Axonics, Inc. | -26.05 Million USD | -4.287% |
| Outset Medical, Inc. | -169.77 Million USD | 83.994% |
| IRIDEX Corporation | -10 Million USD | -171.55% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 75.109% |
| IRadimed Corporation | 20.03 Million USD | 235.63% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -229.582% |
| INVO Bioscience, Inc. | -6.76 Million USD | -301.557% |
| Telesis Bio, Inc. | -35.15 Million USD | 22.691% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 289.63% |
| Varex Imaging Corporation | 32.1 Million USD | 184.654% |
| Quipt Home Medical Corp. | 3.91 Million USD | 793.391% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -123.968% |
| Pulmonx Corporation | -61.93 Million USD | 56.125% |
| Dynatronics Corporation | -2.27 Million USD | -1095.487% |
| Modular Medical, Inc. | -17.52 Million USD | -55.023% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -85.627% |
| Semler Scientific, Inc. | 22.25 Million USD | 222.097% |
| InMode Ltd. | 195.66 Million USD | 113.888% |
| Bruker Corporation | 436.9 Million USD | 106.22% |
| Cytosorbents Corporation | -31.2 Million USD | 12.93% |
| DexCom, Inc. | 597.7 Million USD | 104.546% |
| Align Technology, Inc. | 643.33 Million USD | 104.224% |
| Viveve Medical, Inc. | -21.55 Million USD | -26.08% |
| ZimVie Inc. | -30.93 Million USD | 12.169% |
| Movano Inc. | -29.69 Million USD | 8.474% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 2.41% |
| Nexalin Technology, Inc. | -5.69 Million USD | -377.047% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -670.238% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 88.349% |
| Profound Medical Corp. | -28.61 Million USD | 5.039% |
| Insulet Corporation | 220 Million USD | 112.352% |
| enVVeno Medical Corporation | -25.23 Million USD | -7.671% |
| Surmodics, Inc. | -5.64 Million USD | -381.382% |
| iCAD, Inc. | -7.68 Million USD | -253.414% |
| Nuwellis, Inc. | -17.63 Million USD | -54.135% |
| Biotricity, Inc. | -8.82 Million USD | -207.807% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 78.289% |
| Aethlon Medical, Inc. | -12.63 Million USD | -115.043% |
| InspireMD, Inc. | -21.14 Million USD | -28.525% |
| PAVmed Inc. | -68.79 Million USD | 60.5% |
| BIOLASE, Inc. | -17.93 Million USD | -51.497% |
| Beyond Air, Inc. | -63 Million USD | 56.871% |
| FONAR Corporation | 16.53 Million USD | 264.339% |
| AxoGen, Inc. | -21.46 Million USD | -26.614% |
| Vivani Medical, Inc. | -26.96 Million USD | -0.775% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 250.624% |
| Inari Medical, Inc. | -14.03 Million USD | -93.657% |
| UFP Technologies, Inc. | 57.66 Million USD | 147.125% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -451.465% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -330.939% |
| Tenon Medical, Inc. | -15.72 Million USD | -72.786% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -263.58% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 36.37% |
| AdaptHealth Corp. | -598.4 Million USD | 95.459% |
| Sintx Technologies, Inc. | -13.35 Million USD | -103.429% |
| NanoVibronix, Inc. | -3.43 Million USD | -690.861% |
| Quanterix Corporation | -49.7 Million USD | 45.325% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -123.968% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -7013.613% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 91.875% |
| TransMedics Group, Inc. | -28.72 Million USD | 5.406% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -15.086% |
| NeuroMetrix, Inc. | -7.15 Million USD | -279.975% |
| Hyperfine, Inc. | -48.11 Million USD | 43.523% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 58.211% |
| Biomerica, Inc. | -6.36 Million USD | -326.794% |
| Bone Biologics Corporation | -9.42 Million USD | -188.217% |
| AVITA Medical, Inc. | -40.4 Million USD | 32.741% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -163.538% |
| Silk Road Medical, Inc | -59.27 Million USD | 54.153% |